Related Experiment Video
Updated: Sep 28, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex)
Bruce Friedman1, Hermann K Orlet, Joseph M Still
1Joseph M. Still Burn Center, Doctor's Hospital, Augusta, GA, USA.
Abstract:
A 41-year-old woman was given celecoxib (Celebrex) for the treatment of carpal tunnel syndrome. An erythematous rash developed that progressed to exfoliative dermatitis, and the patient was diagnosed with toxic epidermal necrolysis. After transfer to the burn unit, she was treated with topical mupirocin calcium cream and bismuth tribromophenatein petrolatum gauze dressings. Her wounds healed well. This is the first case report of toxic epidermal necrolysis due to treatment with celecoxib of which we are aware.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug Toxicity: Dose-Dependent Reactions
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drug Toxicity: Overview
Drug toxicity: Drug–Drug Interaction
Drug toxicity: Idiosyncratic Reactions